胃腸道糞便檢驗市場規模、佔有率和成長分析：按檢測類型、技術、臨床應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球消化器官系統(GI)糞便檢驗市場價值為 11.6 億美元，預計到 2025 年將成長至 12.2 億美元，到 2033 年將成長至 18.8 億美元，在預測期（2026-2033 年）內複合年成長率為 5.49%。

全球胃腸道糞便檢驗市場專注於糞便檢體診斷服務，分析多種對診斷感染疾病、腸道菌叢異常和大腸直腸癌至關重要的生物標記。隨著精準醫療採用非侵入性方法，該市場已從基礎的寄生蟲顯微鏡檢查發展到可增強微生物組分析的次世代定序技術。發炎性腸道疾病和大腸癌盛行率的上升推動了對糞便診斷的需求，疾病負擔與市場成長密切相關。此外，美國和歐洲等地區保險報銷制度的改革正在鼓勵多重PCR和糞便DNA檢測的應用，加速了從侵入性檢測到經濟高效的篩檢的轉變。微生物組療法作為藥物的興起進一步推動了實驗室對定序技術的投資，尤其是在新興經濟體，這些地區擁有價格合理的篩檢解決方案。

全球胃腸道糞便檢驗市場的成長要素

隨著預防醫學的日益普及，臨床醫生擴大利用糞便生物標記進行胃腸道疾病的早期檢測。這些非侵入性檢測能夠在症狀出現之前發現疾病，最終改善患者預後並簡化治療方案。因此，在強調腸道健康與更廣泛的系統性問題之間聯繫的宣傳活動的推動下，醫院和門診機構正將糞便檢驗納入標準健康管理方案。這種日益增強的意識正促使醫療服務提供者將糞便檢驗作為一項重要的預防措施進行標準化，從而改善對患者健康的長期監測並促進胃腸道疾病的主動管理。

全球消化器官系統糞便檢驗市場的限制因素

主要市場法律規範的差異給尋求消化器官系統糞便檢驗產品批准的製造商帶來了挑戰。檢驗要求和分類標準的差異迫使企業投入額外資源進行合規性測試和文件編制。這種分散的環境可能導致市場准入延遲和研發週期延長，可能阻礙小規模創新企業開發糞便檢驗平台。因此，新產品上市速度往往放緩，阻礙消化器官系統糞便檢驗市場的整體成長，並可能因阻礙與國際公司建立合作關係而限制業務拓展機會。

全球消化器官系統糞便檢驗市場趨勢

全球胃腸道糞便檢驗市場正經歷著向精準微生物組分析的顯著轉變，這主要得益於定序技術的進步，這些技術能夠提供與胃腸道疾病相關的細菌特徵的詳細資訊。醫療專業人員正日益接受這些創新技術，以實現診斷和治療方案的個人化，從而增強他們監測疾病進展和預測治療反應的能力。隨著患者對「腸-腦軸」的認知不斷提高，對個人化診斷的需求也在不斷成長，實驗室正將全面的糞便分析納入標準流程。這一趨勢正在推動對檢測平台的投資，並促使參與企業包括醫院和專科診所在內的各種醫療機構市場。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球胃腸道糞便檢驗市場規模：依檢測類型分類

• 分子診斷測試
• 基於試劑的測試
• 顯微鏡檢查
• 其他

全球胃腸道糞便檢驗市場規模：依技術分類

• 聚合酵素鏈鎖反應
• 酵素免疫分析法（ELISA）
• 側向流動免疫檢測
• 快速診斷測試
• 其他

全球胃腸道糞便檢驗市場規模：依臨床應用分類

• 細菌感染疾病
• 病毒感染疾病
• 寄生蟲感染疾病
• 發炎性腸道疾病
• 大腸直腸癌篩檢
• 其他

全球胃腸道糞便檢驗市場規模：依最終用戶分類

• 醫院
• 診斷檢查室
• 門診手術中心
• 學術研究機構
• 其他

全球胃腸道糞便檢驗市場規模：按地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Exact Sciences Corporation
• QIAGEN NV
• Danaher Corporation
• F. Hoffmann-La Roche Ltd
• Hologic, Inc.
• bioMerieux SA
• Abbott Laboratories
• DiaSorin SpA
• Meridian Bioscience, Inc.
• Becton, Dickinson and Company
• QuidelOrtho Corporation
• Thermo Fisher Scientific Inc.
• Bio-Rad Laboratories, Inc.
• LumiraDx Limited
• Sunsure Biotech Co., Ltd.
• R-Biopharm AG
• Coris BioConcept
• Alpha Laboratories Ltd.
• CerTest Biotec SL
• Epitope Diagnostics, Inc.

結論與建議

Global Gi Stool Testing Market size was valued at USD 1.16 Billion in 2024 and is poised to grow from USD 1.22 Billion in 2025 to USD 1.88 Billion by 2033, growing at a CAGR of 5.49% during the forecast period (2026-2033).

The global gastrointestinal (GI) stool testing market focuses on diagnostic services analyzing fecal samples for various biomarkers, crucial for diagnosing infections, dysbiosis, and colorectal cancer. As precision medicine embraces non-invasive methods, the market has evolved from basic parasite microscopy to advanced next-generation sequencing technologies, enhancing microbiome profiling. The increasing prevalence of inflammatory bowel disease and colorectal cancer is driving demand for stool-based diagnostics, linking disease burden with market growth. Additionally, reimbursement reforms in regions like the United States and Europe have favored multiplex PCR and stool DNA assays, leading to a shift from invasive procedures to cost-effective screening. The rise of pharmaceutical microbiome therapeutics further stimulates laboratory investment in sequencing technologies, particularly in emerging economies with affordable screening solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Gi Stool Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Gi Stool Testing Market Segments Analysis

Global gi stool testing market is segmented by test type, technology, clinical application, end user and region. Based on test type, the market is segmented into Molecular Diagnostic Tests, Reagent-Based Tests, Microscopic Examinations and Others. Based on technology, the market is segmented into Polymerase Chain Reaction, Enzyme-Linked Immunosorbent Assay, Lateral Flow Immunoassay, Rapid Diagnostic Tests and Others. Based on clinical application, the market is segmented into Bacterial Infections, Viral Infections, Parasitic Infections, Inflammatory Bowel Disease, Colorectal Cancer Screening and Others. Based on end user, the market is segmented into Hospitals, Diagnostic Laboratories, Ambulatory Surgical Centers, Academic Research Institutes and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Gi Stool Testing Market

The increasing focus on preventive healthcare is driving clinicians to utilize stool-based biomarkers for the early identification of gastrointestinal disorders. These non-invasive tests facilitate the detection of diseases prior to the onset of symptoms, ultimately enhancing patient outcomes and simplifying treatment protocols. Consequently, hospitals and outpatient facilities are incorporating stool testing into their standard wellness programs, buoyed by educational initiatives that emphasize the link between gut health and broader systemic issues. This growing awareness encourages healthcare providers to standardize stool testing as a crucial preventive measure, thereby improving the long-term monitoring of patient health and promoting proactive management of gastrointestinal conditions.

Restraints in the Global Gi Stool Testing Market

The diverse regulatory frameworks across key markets present challenges for manufacturers aiming to secure product approvals in the GI stool testing sector. Variations in validation requirements and classification criteria lead companies to invest extra resources in compliance testing and documentation. This fragmented environment can result in delays in market entry and extend development timelines, which may discourage smaller innovators from pursuing stool-based platforms. As a result, the introduction of new products tends to slow down, hindering the overall growth of the global GI stool testing market and potentially discouraging foreign partnerships, which further limits opportunities for expansion.

Market Trends of the Global Gi Stool Testing Market

The Global Gi Stool Testing market is experiencing a significant shift towards precision microbiome profiling, influenced by advancements in sequencing technologies that offer detailed insights into bacterial signatures associated with gastrointestinal disorders. Healthcare providers are increasingly embracing these innovations to personalize diagnostics and treatment plans, enhancing their ability to monitor disease progression and predict therapeutic responses. As awareness of the gut-brain axis grows among patients, there is a rising demand for tailored diagnostics, prompting laboratories to incorporate comprehensive stool analysis into standard care practices. This trend is driving investment in testing platforms and expanding market participation across various healthcare settings, including hospitals and specialty clinics.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global GI Stool Testing Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Molecular Diagnostic Tests
• Reagent-Based Tests
• Microscopic Examinations
• Others

Global GI Stool Testing Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Polymerase Chain Reaction
• Enzyme-Linked Immunosorbent Assay
• Lateral Flow Immunoassay
• Rapid Diagnostic Tests
• Others

Global GI Stool Testing Market Size by Clinical Application & CAGR (2026-2033)

• Market Overview
• Bacterial Infections
• Viral Infections
• Parasitic Infections
• Inflammatory Bowel Disease
• Colorectal Cancer Screening
• Others

Global GI Stool Testing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Ambulatory Surgical Centers
• Academic Research Institutes
• Others

Global GI Stool Testing Market Size & CAGR (2026-2033)

• North America (Test Type, Technology, Clinical Application, End User)
  • US
  • Canada
• Europe (Test Type, Technology, Clinical Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Technology, Clinical Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Technology, Clinical Application, End User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Technology, Clinical Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Exact Sciences Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meridian Bioscience, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LumiraDx Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sunsure Biotech Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• R-Biopharm AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coris BioConcept
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alpha Laboratories Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CerTest Biotec S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epitope Diagnostics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations